Long-term outcomes of thalidomide in pediatric Crohn's disease.

Lin WangAijuan XueCuifang ZhengYing ZhouYuhuan WangYing Huang

Published in: Journal of gastroenterology and hepatology (2019)

Thalidomide was clinically efficacious and safe among pediatric CD. Our results suggest that it is an alternative therapy in monogenic mutation patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
young adults
mesenchymal stem cells